• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur J Prev Cardiol . Recent COVID-19 and mortality after myocardial infarction: a Danish nationwide cohort study

tetano

Editor, Senior Moderator
Eur J Prev Cardiol


. 2025 Aug 28:zwaf538.
doi: 10.1093/eurjpc/zwaf538. Online ahead of print. Recent COVID-19 and mortality after myocardial infarction: a Danish nationwide cohort study

Katrine D Brodersen[SUP] 1 2 [/SUP], Sinna P Ulrichsen[SUP] 1 2 [/SUP], Signe Sørup[SUP] 1 2 [/SUP], Lars Pedersen[SUP] 1 2 [/SUP], Reimar W Thomsen[SUP] 1 2 [/SUP], Henrik T Sørensen[SUP] 1 2 [/SUP], Morten Schmidt[SUP] 1 2 3 [/SUP]



Affiliations
Abstract

Aims: Coronavirus disease 2019 (COVID-19) may trigger myocardial infarction (MI). However, the outcomes of MI following recent COVID-19 remain largely unexplored. Consequently, we examined the association between recent COVID-19 and mortality after MI and the prognostic importance of COVID-19 vaccination.
Methods: With data from linked Danish registries, we conducted a nationwide, population-based cohort study including adults admitted with a first-time MI to a Danish hospital from May 26, 2020, to March 9, 2022. The exposure was recent COVID-19 (positive polymerase chain reaction test in the period from 90 days before to the day after MI). Primary outcomes were all-cause mortality within 30 or 180 days after MI. We calculated absolute risk estimates and computed hazard ratios (HRs) with 95% confidence intervals (CIs) with a Cox proportional-hazards regression controlled for age, sex, comorbidity burden, and use of selected drugs using stabilized inverse probability weighting. We stratified by prior COVID-19 vaccination.
Results: Of 12,054 included MI patients, 337 had recent COVID-19. Comparison of MI patients with versus without recent COVID-19 yielded an adjusted HR of 1.64 (95% CI: 1.16-2.31) for 30-day mortality and 1.28 (95% CI: 0.92-1.78) for 180-day mortality after MI. The adjusted HR was higher among unvaccinated MI patients (2.88, 95% CI: 1.78-4.64 for 30-day mortality; 2.09, 95% CI: 1.30-3.36 for 180-day mortality) than vaccinated patients (1.11, 95% CI: 0.65-1.90 and 0.97, 95% CI: 0.60-1.56, respectively).
Conclusion: Recent COVID-19 was associated with increased short-term mortality after MI in patients without prior COVID-19 vaccination.

Keywords: COVID-19; immunization; myocardial infarction; prognosis.

 
Back
Top Bottom